BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 30413158)

  • 1. Therapeutic potential of products derived from mesenchymal stem/stromal cells in pulmonary disease.
    Mohammadipoor A; Antebi B; Batchinsky AI; Cancio LC
    Respir Res; 2018 Nov; 19(1):218. PubMed ID: 30413158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Use of Extracellular Vesicles for Acute and Chronic Lung Disease.
    Worthington EN; Hagood JS
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cell derived secretome and extracellular vesicles for acute lung injury and other inflammatory lung diseases.
    Monsel A; Zhu YG; Gudapati V; Lim H; Lee JW
    Expert Opin Biol Ther; 2016 Jul; 16(7):859-71. PubMed ID: 27011289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem/stromal cell secretome for lung regeneration: The long way through "pharmaceuticalization" for the best formulation.
    Bari E; Ferrarotti I; Torre ML; Corsico AG; Perteghella S
    J Control Release; 2019 Sep; 309():11-24. PubMed ID: 31326462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Lung Diseases: Current Status and Future Perspectives.
    Guo H; Su Y; Deng F
    Stem Cell Rev Rep; 2021 Apr; 17(2):440-458. PubMed ID: 33211245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of mesenchymal stem/stromal cell-derived secretome and vesicles for lung injury and disease.
    Liu A; Zhang X; He H; Zhou L; Naito Y; Sugita S; Lee JW
    Expert Opin Biol Ther; 2020 Feb; 20(2):125-140. PubMed ID: 31701782
    [No Abstract]   [Full Text] [Related]  

  • 7. Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression.
    Doeppner TR; Herz J; Görgens A; Schlechter J; Ludwig AK; Radtke S; de Miroschedji K; Horn PA; Giebel B; Hermann DM
    Stem Cells Transl Med; 2015 Oct; 4(10):1131-43. PubMed ID: 26339036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory Effects of Mesenchymal Stem Cells and their Secretomes in Pneumonia.
    Hezam K; Mo R; Wang C; Liu Y; Li Z
    Curr Pharm Biotechnol; 2022; 23(9):1153-1167. PubMed ID: 34493193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal Stem Cell-derived Extracellular Vesicles for Renal Repair.
    Nargesi AA; Lerman LO; Eirin A
    Curr Gene Ther; 2017; 17(1):29-42. PubMed ID: 28403795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular vesicles derived from mesenchymal stromal cells: a therapeutic option in respiratory diseases?
    Abreu SC; Weiss DJ; Rocco PR
    Stem Cell Res Ther; 2016 Apr; 7(1):53. PubMed ID: 27075363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal Stromal Cell Secretome: Influencing Therapeutic Potential by Cellular Pre-conditioning.
    Ferreira JR; Teixeira GQ; Santos SG; Barbosa MA; Almeida-Porada G; Gonçalves RM
    Front Immunol; 2018; 9():2837. PubMed ID: 30564236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Good Manufacturing Practice-grade standard protocol for exclusively human mesenchymal stromal cell-derived extracellular vesicles.
    Pachler K; Lener T; Streif D; Dunai ZA; Desgeorges A; Feichtner M; Öller M; Schallmoser K; Rohde E; Gimona M
    Cytotherapy; 2017 Apr; 19(4):458-472. PubMed ID: 28188071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal Stem Cell Derived Extracellular Vesicles: A Role in Hematopoietic Transplantation?
    De Luca L; Trino S; Laurenzana I; Lamorte D; Caivano A; Del Vecchio L; Musto P
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28486431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Extracellular Vesicles Derived from Mesenchymal Stem/Stromal Cells on Liver Diseases.
    Zheng W; Yang Y; Sequeira RC; Bishop CE; Atala A; Gu Z; Zhao W
    Curr Stem Cell Res Ther; 2019; 14(5):442-452. PubMed ID: 30854976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cell trials for pulmonary diseases.
    Antunes MA; Laffey JG; Pelosi P; Rocco PR
    J Cell Biochem; 2014 Jun; 115(6):1023-32. PubMed ID: 24515922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placenta Stem/Stromal Cell-Derived Extracellular Vesicles for Potential Use in Lung Repair.
    Kim SY; Joglekar MV; Hardikar AA; Phan TH; Khanal D; Tharkar P; Limantoro C; Johnson J; Kalionis B; Chrzanowski W
    Proteomics; 2019 Sep; 19(17):e1800166. PubMed ID: 31318160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal Stromal Cells Modulate Macrophages in Clinically Relevant Lung Injury Models by Extracellular Vesicle Mitochondrial Transfer.
    Morrison TJ; Jackson MV; Cunningham EK; Kissenpfennig A; McAuley DF; O'Kane CM; Krasnodembskaya AD
    Am J Respir Crit Care Med; 2017 Nov; 196(10):1275-1286. PubMed ID: 28598224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic use of mesenchymal stem cell-derived extracellular vesicles in acute lung injury.
    Lee JH; Park J; Lee JW
    Transfusion; 2019 Feb; 59(S1):876-883. PubMed ID: 30383895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal Regenerative Potential of Extracellular Vesicles Derived from miRNA-Engineered Mesenchymal Stromal Cells.
    Tapparo M; Bruno S; Collino F; Togliatto G; Deregibus MC; Provero P; Wen S; Quesenberry PJ; Camussi G
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31091699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential of mesenchymal stem cell therapy for chronic lung disease.
    Cruz FF; Rocco PRM
    Expert Rev Respir Med; 2020 Jan; 14(1):31-39. PubMed ID: 31608724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.